Published in Medical Letter on the CDC and FDA, April 13th, 2003
According to a study from France, "The aim of this work was to compare in vitro the performances at delivering nicotine of two transdermal delivery system (TDS): Nicorette (8.3 mg/10 cm2 nicotine content) and Nicopatch (17.5 mg/10 cm2)."
"Release profiles were obtained using the FDA paddle method, and skin permeation profiles using Franz-type diffusion cells," reported Jean-Christopher Olivier and colleagues at the Faculte de Medecine et de Pharmacie. "Using the first method, nicotine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA